Dirk Nagorsen
- Immunology top 1%
- Immunotherapy and Immune Responses 45
- T-cell and B-cell Immunology 25
- Immune Cell Function and Interaction 19
- Oncology top 1%
- CAR-T cell therapy research 43
- Cancer Immunotherapy and Biomarkers 22
- Hematology top 2%
-
- Lymphoma Diagnosis and Treatment 14
-
- Monoclonal and Polyclonal Antibodies Research 13
-
- vaccines and immunoinformatics approaches 11
- Co-authors
- Patrick A. BaeuerleEckhard ThielRalf C. BargouUlrich KeilholzCarmen ScheibenbogenPeter KuferAnne LetschFrancesco M. Marincola
- Cited by
- ImmunologyOncologyHematology
- Journals
- Journal of Clinical Oncology (7 papers)Blood (17 papers)The Journal of Immunology (2 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Dirk Nagorsen
88 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Immunology 2.3k
- Oncology 2.7k
- Hematology 616
- Pathology and Forensic Medicine 682
- Radiology, Nuclear Medicine and Imaging 711
Countries citing papers authored by Dirk Nagorsen
This map shows the geographic impact of Dirk Nagorsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Nagorsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Nagorsen more than expected).
Fields of papers citing papers by Dirk Nagorsen
This network shows the impact of papers produced by Dirk Nagorsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Nagorsen. The network helps show where Dirk Nagorsen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dirk Nagorsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemiabreakdown → | 2018 | 516 |
| 2 | 2017 | 157 | |
| 3 | 2015 | 53 | |
| 4 | 2013 | 69 | |
| 5 | 2010 | 12 | |
| 6 | 2009 | 63 | |
| 7 | 2009 | 56 | |
| 8 | 2008 | 7 | |
| 9 | 2007 | 181 | |
| 10 | 2006 | 11 | |
| 11 | 2006 | 8 | |
| 12 | 2006 | 5 | |
| 13 | 2005 | 22 | |
| 14 | 2004 | 50 | |
| 15 | 2003 | 15 | |
| 16 | 2002 | 68 | |
| 17 | 2002 | 5 | |
| 18 | 2002 | 26 | |
| 19 | 2002 | 17 | |
| 20 | 2001 | 60 |
About Dirk Nagorsen
Dirk Nagorsen is a scholar working on Immunology, Oncology and Genetics, having authored 88 papers that have together received 4.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (45 papers), CAR-T cell therapy research (43 papers), T-cell and B-cell Immunology (25 papers), Cancer Immunotherapy and Biomarkers (22 papers), Immune Cell Function and Interaction (19 papers), Lymphoma Diagnosis and Treatment (14 papers), Monoclonal and Polyclonal Antibodies Research (13 papers) and vaccines and immunoinformatics approaches (11 papers). The work is most often cited by research in Immunology (2.3k citations), Oncology (2.7k citations) and Hematology (616 citations). Dirk Nagorsen has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Patrick A. Baeuerle, Eckhard Thiel, Ralf C. Bargou, Ulrich Keilholz, Carmen Scheibenbogen, Peter Kufer, Anne Letsch, Francesco M. Marincola, Julia Stieglmaier and Gerhard Zugmaier. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.